- Home
- OMDA vs MDXG Comparison
OMDA vs MDXG Comparison
Compare OMDA & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMDA
- MDXG
- Stock Information
- Founded
- OMDA 2011
- MDXG 2006
- Country
- OMDA United States
- MDXG United States
- Employees
- OMDA N/A
- MDXG N/A
- Industry
- OMDA Medical/Nursing Services
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- OMDA Health Care
- MDXG Health Care
- Exchange
- OMDA Nasdaq
- MDXG Nasdaq
- Market Cap
- OMDA 1.3B
- MDXG 1.0B
- IPO Year
- OMDA 2025
- MDXG N/A
- Fundamental
- Price
- OMDA $24.57
- MDXG $7.65
- Analyst Decision
- OMDA Strong Buy
- MDXG Buy
- Analyst Count
- OMDA 7
- MDXG 1
- Target Price
- OMDA $25.43
- MDXG $12.00
- AVG Volume (30 Days)
- OMDA 327.6K
- MDXG 972.3K
- Earning Date
- OMDA 11-06-2025
- MDXG 10-29-2025
- Dividend Yield
- OMDA N/A
- MDXG N/A
- EPS Growth
- OMDA N/A
- MDXG N/A
- EPS
- OMDA N/A
- MDXG 0.27
- Revenue
- OMDA $209,827,000.00
- MDXG $393,442,000.00
- Revenue This Year
- OMDA $43.42
- MDXG $12.68
- Revenue Next Year
- OMDA $20.01
- MDXG $8.18
- P/E Ratio
- OMDA N/A
- MDXG $28.33
- Revenue Growth
- OMDA 135.27
- MDXG 14.77
- 52 Week Low
- OMDA $14.14
- MDXG $5.79
- 52 Week High
- OMDA $28.40
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- OMDA N/A
- MDXG 70.23
- Support Level
- OMDA N/A
- MDXG $6.68
- Resistance Level
- OMDA N/A
- MDXG $7.89
- Average True Range (ATR)
- OMDA 0.00
- MDXG 0.28
- MACD
- OMDA 0.00
- MDXG 0.10
- Stochastic Oscillator
- OMDA 0.00
- MDXG 83.78
About OMDA Omada Health Inc. Common Stock
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.